Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @DukeMargolis
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DukeMargolis
-
And that’s all for now folks. Thanks for joining us today! You can find meeting materials and a recording of the webcast here: https://healthpolicy.duke.edu/events/trust-verify-informational-challenges-surrounding-ai-enabled-clinical-decision-software …
#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Moderator Arti Rai
@rai_arti@DukeCIP with a question for the panel: "If you were to claim a training model, what kind of disclosure would you need to have?"#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Should we have a type of database protection or incentive here? I would say it depends on the context." - Kate Gaudry
@KTS_Law#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"You should be able to make your algorithm work on less and less data, or worse and worse data. Essentially, you should be able to retest to prove the value of your AI product." - Brigham Hyde
@BrighamHyde#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We are in a true information age. Though some things are kept as trade secrets, there is a need to share and exchange information." - Michele Conover
@SiemensHealth#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"The choice and tuning of the algorithmic model (how you're setting it up), the weighting of the features, and the feature selection are where a lot of trade secrecy lives in companies that I've been involved in." - VC Brigham Hyde
@BrighamHyde#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Patenting prospects of software and
#AI innovations have been volatile in the US." - Kate Gaudry@KTS_Law#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Developers/VCs consider reproductive information as a core advantage that they may not want to disclose to regulatory agencies like FDA." - Arti Rai
@rai_arti@DukeCIP#TrustButVerifypic.twitter.com/QCLdtD2jtH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We feel strongly that patent rights are the preferable way of incentivizing innovation in this area because, if people keep trade secrets, we won't have an exchange of information." - Coke Stewart
@uspto#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Now for Session II - The Role of Innovation Incentives for
#AI in#Healthcare moderated by Arti Rai@rai_arti@DukeCIP. Here we will delve into the role that#patents and#tradesecrets play, as well as how#FDA regulation affects innovation.#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"What about an
#AI machine that contributes to a new diagnostic process? Should they be listed as an inventor?" - Laura Peter@uspto#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Keynote speaker Deputy Director Laura Peter
@uspto on Blazing a Trail Together for the Next#AI Revolution - "Can an entity other than a natural person be an inventor on a US patent?"#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
And we're back! Arti Rai
@rai_arti@DukeCIP kicks things off with a few quick remarks on trade secrecy and#AI.#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We'll be back at 3:05 pm ET after a short break! https://healthpolicy.duke.edu/events/trust-verify-informational-challenges-surrounding-ai-enabled-clinical-decision-software …
#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Question from the audience: "For those who are poor and don't have robust health records, there is going to be a gap for those seeking care due to incomplete data being fed into algorithms. What happens then?"
#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"There is a biased set of inputs that these systems are being trained on. It's important to think of what would bias look like in the outputs, and how do we look for these anomalies during testing." - Carey Morewedge
@morewedge@BUQuestrom#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Moderator Mark McClellan
@DukeMargolis with a question to the panel: "How do you fail gracefully? There are going to be imperfections and mistakes along the way-- how do you account for them?"#TrustButVerify#AIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Working on getting autonomous
#AI to patients helps lower costs, improve quality, and improve access." - Michael Abramoff@EyeDiagnosis#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Patients tend to be fine with an
#AI system providing input as long as there is a human verifying the output, and allowing adopters to have a modicum of control increases uptake. - Carey Morewedge@morewedge@BUQuestrom#TrustButVerifyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Always approach this issue by asking how the AI system would function at the point-of-care. If you are a large health system, it is quite different than if you are a small practice. We don't want
#AI to worsen health disparities." - Kathleen Blake@AmerMedicalAssnHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.